Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 3.
作者信息
Rigatto Claudio
机构信息
Section of Nephrology, Rady Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada and Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg, Manitoba, Canada.
出版信息
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2097. doi: 10.2215/CJN.09230816. Epub 2016 Oct 25.
Abstract
摘要
相似文献
1
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 3.终末期肾病患者心房颤动管理中口服抗凝药的应用：裁决3
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2097. doi: 10.2215/CJN.09230816. Epub 2016 Oct 25.
2
Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1.口服抗凝药在接受血液透析的终末期肾病合并心房颤动患者中的应用：结论1
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2093-2094. doi: 10.2215/CJN.08610816. Epub 2016 Oct 25.
3
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2.终末期肾病患者心房颤动管理中口服抗凝药的应用：裁决2
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2095-2096. doi: 10.2215/CJN.09470916. Epub 2016 Oct 25.
4
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.终末期肾病患者心房颤动管理中口服抗凝药的应用：专家共识
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2079-2084. doi: 10.2215/CJN.02680316. Epub 2016 Oct 25.
5
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction.终末期肾病患者心房颤动管理中口服抗凝药的应用：引言。
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2078. doi: 10.2215/CJN.09700916.
6
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.终末期肾病患者心房颤动管理中口服抗凝药的应用：反对观点
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2085-2092. doi: 10.2215/CJN.03200316. Epub 2016 Oct 25.
7
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.口服抗凝药物与伴有终末期肾病的心房颤动患者的心血管结局。
J Am Coll Cardiol. 2020 Mar 24;75(11):1299-1308. doi: 10.1016/j.jacc.2020.01.019.
8
Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.口服抗凝剂在心房颤动和终末期肾病患者中的应用。
J Cardiovasc Pharmacol Ther. 2019 Nov;24(6):499-508. doi: 10.1177/1074248419858116. Epub 2019 Jul 8.
9
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.口服抗凝剂预防 CKD 5D 期非瓣膜性心房颤动患者卒中：NKF-KDOQI 争议报告。
Am J Kidney Dis. 2017 Dec;70(6):859-868. doi: 10.1053/j.ajkd.2017.08.003. Epub 2017 Sep 21.
10
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
引用本文的文献
1
Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.种族、明显残疾与房颤合并维持性血液透析患者华法林处方相关性研究。
Am J Cardiol. 2019 Feb 15;123(4):598-604. doi: 10.1016/j.amjcard.2018.11.020. Epub 2018 Nov 24.
Zotero 插件